Citadel Advisors - VERRICA PHARMACEUTICALS INC ownership

VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 68 filers reported holding VERRICA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 8.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of VERRICA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$112,215
-82.0%
28,884
-73.3%
0.00%
Q2 2023$623,893
+16.2%
108,127
+31.0%
0.00%
Q1 2023$536,692
+39.2%
82,568
-41.1%
0.00%
Q4 2022$385,685
+7.7%
140,249
+14.6%
0.00%
Q3 2022$358,000
+155.7%
122,354
+68.3%
0.00%
Q2 2022$140,000
-41.7%
72,705
+145.3%
0.00%
Q1 2022$240,000
-46.7%
29,640
-17.7%
0.00%
Q3 2021$450,00036,0000.00%
Other shareholders
VERRICA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 5,038,983$19,576,4480.65%
BML Capital Management, LLC 150,000$582,7500.54%
Caligan Partners LP 259,593$1,009,8170.46%
Avoro Capital Advisors LLC 2,954,064$11,476,5390.18%
Boxer Capital, LLC 166,955$648,6200.04%
SteelPeak Wealth, LLC 136,986$532,1910.03%
Legacy Trust 18,750$72,8440.02%
Miracle Mile Advisors, LLC 118,221$459,2890.01%
SPC Financial, Inc. 30,000$116,5500.01%
KORNITZER CAPITAL MANAGEMENT INC /KS 99,251$385,5900.01%
View complete list of VERRICA PHARMACEUTICALS INC shareholders